Why the study?
Deciding when to restart antiplatelet or anticoagulation agents after peptic ulcer bleeding is challenging because the risks of rebleeding and thromboembolism must be balanced.
When should antiplatelet and anticoagulation agents be restarted after peptic ulcer bleeding in patients with cardiovascular and cerebrovascular diseases?
When should antiplatelet and anticoagulation agents be restarted after peptic ulcer bleeding in patients with cardiovascular and cerebrovascular diseases?
Provides updated Korean guidelines on balancing the risks of rebleeding and thromboembolism when restarting antithrombotic therapy after peptic ulcer bleeding.
Early resumption of aspirin after hemostasis may reduce thromboembolic events; leaves open optimal timing for other agents pending higher-level trials.
No takes yet. Share an insight, caveat, or question.
Hyo‐Joon Yang (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: